Can obese patients benefit from the Coronary CTA pathway to diagnose Coronary Artery Disease?
By
HeartFlow
FEATURING
Maros Ferencik
By
HeartFlow
FEATURING
Maros Ferencik
Dr. Maros Ferencik reviews insights from the PRECISE Trial sub study evaluating the difference in test results and outcomes between obese and non-obese patients using a usual testing strategy or coronary computed tomography (CCTA) with selective noninvasive fractional flow reserve (FFRCT).
Login to view comments.
Click here to Login
